Cargando…
Metformin, chronic nephropathy and lactic acidosis: a multi-faceted issue for the nephrologist
Metformin is currently considered a first-line therapy in type 2 diabetic patients. After issuing warnings for decades about the risks of lactic acidosis in patients with chronic nephropathy, metformin is now being re-evaluated. The most recent evidence from the literature has demonstrated both a lo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357762/ https://www.ncbi.nlm.nih.gov/pubmed/33373028 http://dx.doi.org/10.1007/s40620-020-00941-8 |